Going Bearish on Earnings Reporters

Options Review:

We’ve been back on our Midas Touch options trading business over the last several sessions, and yesterday morning was no different. We were just patting ourselves on the back for 100% accuracy on the previous session’s bangers, and we managed to do it again to start this holiday-shortened week.

We signaled ranges on a couple of plays, highlighting the SPY 11/22 $469-470 Calls, as well as going short on the CRNC 12/17 $105-95 Puts. Both turned out to be excellent notions, and the board was fully green for yet another day. The end of this week will be rather subdued, with a day off for Thanksgiving and just a half trading day for Black Friday, so it’s good we’re getting these in now.

Here are the total possible profits that could have been banked off of yesterday’s targets:

SPY 11/22 $469-470 Calls
$469:
 1.99-4.50 (+126%)
$470: .62-2.40 (+287%)
_____

CRNC 12/17 $105-95 Puts 
$105: 15.00-22.46 (+50%)
$100: 9.70-18.20 (+88%)
$95: 6.00-13.49 (+125%)


Fresh Options Ideas: 
URBN Weekly $35-33 Puts
DLTR Weekly $132-130 Puts
BBY Weekly $122-119 Puts


Extended Watchlist: 
ISPC, KTTA, PTPI, APVO, QLGN, AADI, TNXP, OSCI, VIZC, PUGE, TIPS, LVGI

More Multi-bag Options Runners

CURE Pharmaceutical Holding Corp. CURR

We find CURR very interesting because of the company’s unique systems/methods for delivering drugs into the human body. It’s not often that we run into an OTC traded play with intriguing proprietary technologies.

The Company’s efforts to further position itself as an integrated healthcare company with its recent acquisition of The Sera Labs, a high-margin, multi-channel marketing and branding company with accelerating sales of its more than 20 products in the health & wellness, beauty, and pets categories and strong traction in both e-commerce and wholesale-to-retail distribution with total retail doors exceeding 8,850 in the U.S. to date. CURE acquired 100 percent of privately held The Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition.

The Sera Labs newest consumer product that uses CURE’s patented and advanced oral thin film strip technology under the trademark name Nutri-Strips with RAD3 (Rapid Activation Delivery) to deliver novel vitamins and supplements to consumers across the nation.

The Company’s future plans and focus on research and development into CURE’s pharmaceutical programs and The Sera Labs commitment to innovating its offerings with a “tele-wellness” program and exciting new products.

In addition to an interesting backstory the CURR chart itself looks rather attractive at the moment. The stock has just bounced off of its 52-week low, with a recent increase in volume. The PPS over the last two sessions has held a higher low, so we’ll be looking for the further establishment of higher highs and higher lows off of its bottom. Key resistance points to note are the 50DMA at 1.22 and the 200DMA at 1.73. We are definitely going to put this play on our watchlist this today and continue to track its progress going forward.


Options Recaps

We had a clean sweep on options in yesterday’s report, with each of the three sets of ideas we offered up to our readers performed quite well on the day. Here are the ranges and total potential intraday gains that were on the table:

DLTR Weekly $104-106 Calls
$104
: 2.38-8.11 (+241%)
$105: 1.94-6.94 (+258%)
$106: 1.03-6.45 (+526%)
_____

AMBA Weekly $68.50-70 Calls
$68.50
: 3.28-6.50 (+98%)
$69: 2.20-7.20 (+227%)
$70: 1.55-6.39 (+312%)
_____

NTNX Weekly $30-32 Calls 
$30: .50-1.11 (+222%)
$31: .24-.60 (+250%)
$32: .05-.30 (+500%)


Fresh Options Ideas: 
JWN Weekly $24-26 Calls*
DE Weekly $265-270 Calls*
GAP Weekly $24.50-23.50 Puts*

*Please note that these weekly contracts will expire early on Friday at the 1PM close, following tomorrow’s holiday. We hope everyone has a safe and happy Thanksgiving!


Extended Watchlist:
ENZC, TSNP, HYSR, MGTI

ARSN News, Options Ideas & More

Aureus Inc. – News Update

For our readers who may have missed our initial report on ARSN, you can check that out right here. As for today, the company has issued another press release this morning that we wanted to pass along, regarding the progress on its plans to establish several small retail markets, which we’ve discussed before.

ATLANTA, GA / ACCESSWIRE / November 24, 2020 / Aureus, Inc. (OTC PINK:ARSN) (“Aureus” or the “Company”) (www.AureusNOW.com) an emerging leader in the food brand development industry which owns the Yuengling’s Ice Cream brand (“Yuengling’s Ice Cream” or “Yuengling’s”) (www.yuenglingsicecream.com) including all intellectual property, will diversify its interests into the food sector by developing Micro Markets throughout the metro Atlanta area. This new subsidiary is named Aureus Micro Markets (AureusMicro.co)

CEO Everett Dickson stated: “This was a fantastic week! After spending the last several weeks “seeding” the Metro Atlanta area, our sales this week were ahead of schedule relative to our projections. For us to achieve our goal of 30 locations by year’s end, we needed to secure 15 sites this month. Given our performance this week, we feel that objective is very obtainable. (>>View Full PR via OTC Markets)


RECENT STOCK GAINERS 

DSG Global, Inc. DSGT – We initially signaled DSGT for tracking just over three weeks back, on the 30th of October, subsequent to which point the stock had traded for as little as .1333 per share. In a huge start to the week yesterday, DSGT ran up to a new high of .39. That works out to an increase of 193%

_____

Alpine 4 Technologies, Ltd. ALPP – On Wednesday of last week, we flagged ALPP for the first time in several months, and at that time we observed a low of .0735 in the stock. Yesterday brought a new high of .35 on this play, marking a run of 376% inside of a week.
_____

Blink Charging Co. BLNK – As for BLNK, which first appeared on our watchlist on the morning of September 30th, after which time it would see a low of 7.33. Yesterday’s new high on BLNK came in at 34.67, which represents an overall upswing of 373% since we began tracking the stock.


Fresh Options Ideas:
NTNX Weekly $30-32 Calls
AMBA Weekly $68.50-70 Calls
DLTR Weekly $104-106 Calls


Extended Watchlist:
ADOM, ENZC, JNSH, ADHC